Compare United States Copper Index Fund (CPER) vs Neurocrine Biosciences Inc (NBIX) Price & Performance

United States Copper Index FundTrade

Neurocrine Biosciences IncTrade

Price performance (Past 24H)

Key statistics

United States Copper Index Fund vs Neurocrine Biosciences Inc — how do they compare? United States Copper Index Fund trades at $38.39, while Neurocrine Biosciences Inc trades at $170.05 (market cap $17.30B). Which is the better fit depends on your goals.

	CPER	NBIX
Sector	Commodities - Metals/Agriculture	Health
52-Week High	$40.60	$180.55
52-Week Low	$27.21	$123.10
Market Cap	—	$17.30B
Enterprise Value	—	$16.39B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CPER

Investors choose between copper miners ETF and copper futures fund for EV-driven demand exposure.24/7 Wall Street · 3 days agoBullish View details →

NBIX

Neurocrine shares jump 27% this year on strong sales and pipeline growth.FXEmpire · 4 days agoBullish View details →

About United States Copper Index Fund

CPER is a commodity ETF that tracks the price of copper futures via the SummerHaven Copper Index. It provides direct exposure to the 'red metal' using a rules-based strategy to select futures contracts, making it a key tool for hedging or betting on industrial growth and electrification.

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.